高密度培养重组大肠杆菌发酵生产胆固醇氧化酶的策略

以重组大肠杆菌发酵生产胆固醇氧化酶,依据溶解氧的变化控制底物的流加速率,实现了重组大肠杆菌的高密度培养,最高密度达85（OD600）。在此基础上确定了最佳的诱导时机为发酵中期,菌体产酶水平达5830．6tJ／L,产酶速率为971．77U·L^-1·h^-1,生产强度为388．71U·L^-1·h^-1,实现了胆固醇氧化酶的高效生产。     

吸水链霉菌发酵生产谷氨酰胺转胺酶的补料研究

在吸水链霉菌(Streptomyces hygroscopicus)分批发酵研究的基础上,通过在菌体生长阶段指数流加葡萄糖,进行高细胞密度培养,获得了较高的菌体量;待菌体生长进入产酶期后,通过补加氮源,为产酶提供充足的氮源,其中通过流加蛋白质氮源,可以减少蛋白酶对成熟MTG的分解,促进产酶。结果表明,8~16 h采用较高的的比生长速率(0.15 h-1),后期降低比生长速率(0.10 h-1),此时得到的菌体量较高,可达到36 g/L,比分批发酵下的菌体量提高了80%。同时在培养基中添加50g/L的豆饼粉,最终酶活可达到5.79U/ml,提高了83%。     

单因素优化提高重组毕赤酵母β-呋喃果糖苷酶产量

产生低聚果糖的β-呋喃果糖苷酶(β-fructofuranosidase,FFase)是一种具有广泛应用前景的工业酶。为了提高重组毕赤酵母生产FFase的产量,对重组毕赤酵母接种量、摇瓶装液量、甲醇添加量、山梨醇与甲醇共混4个因素进行单因素优化。研究结果表明,接种量为5%时酶活力达到8.35 U/m L,甲醇添加量为0.8%时酶活力达到6.89 U/m L,山梨醇添加量为1.5%时酶活力达到9.49 U/m L,装液量为20 m L时酶活力达到27.34 U/m L。在最优条件下诱导重组毕赤酵母,FFase酶活可达到33.46 U/m L,较优化前提高了4.86倍。该研究为进一步优化毕赤酵母FFase发酵条件和提高FFase产量奠定了一定基础。     

耐有机溶剂果糖苷酶的胞外表达、纯化和结晶

【目的】克隆表达一种Arthrobacter arilaitensis NJEM01来源的耐有机溶剂β-呋喃果糖苷酶(β-FFase),纯化并进行结晶条件的研究。【方法】构建pelB信号肽与β-FFase融合表达质粒pET22b-pelB-bff,将其导入Escherichia coli BL21(DE3)中诱导表达,硫酸铵沉淀、DEAE阴离子交换色谱两步纯化重组蛋白,采用坐滴式气相扩散法对β-FFase进行结晶条件筛选和优化。【结果】构建重组质粒pET22b-pelB-bff,通过优化诱导表达条件,IPTG浓度0.1 mmol/L,诱导温度30 °C,诱导时间10 h,比活力高达108 U/mg,实现了果糖苷酶的胞外可溶性表达,纯化获得达到结晶纯度的β-FFase。结晶条件初筛和优化后获得可培养β-FFase晶体的条件为0.15 mol/L氯化钙,0.1 mol/L HEPES pH 6.7,26%聚乙二醇400。晶体衍射分辨率可以达到2.1 ?。【结论】高糖苷合成能力β-FFase表达纯化体系的构建和结晶条件的初步研究,为从结构生物学角度进一步研究果糖苷酶结构与功能的关系,定向进化提高糖苷酶转糖基活性奠定了基础。     

重组毕赤酵母生产β-葡萄糖苷酶发酵条件初步研究

为提高重组毕赤酵母(P.pastoris KM71/pPIC9K-bgl)生产β-葡萄糖苷酶的产量,在摇瓶条件下对重组P.pastoris产β-葡萄糖苷酶的发酵过程进行了优化,得到最佳的条件:生长阶段甘油浓度为30 g/L,接种量为10%,诱导阶段甲醇的初浓度为4%,过程补加甲醇0.5%,诱导温度30℃,pH7.5,诱导周期120 h,酶活可达到245 U/mL。在此基础上,在3 L发酵罐上进行初步放大,流加甘油提高细胞密度至OD_(600)为170,开始流加甲醇诱导,最终BGL酶活达到1 175 U/mL。比摇瓶提高了4.8倍,为β-葡萄糖苷酶工业化生产打下了坚实的基础。     

大肠杆菌BL21(DE3)膜组分相关基因的敲除对重组蛋白胞外分泌的影响

摘要:【目的】探究Escherichia coli BL21(DE3)中膜组分相关的脂多糖合成基因waaF或msbB的敲除对重组蛋白胞外分泌的影响。【方法】运用Red重组技术将E.coli BL21 (DE3)染色体上的基因waaF或msbB敲除,构建敲除菌株E.coli BL21(ΔwaaF)、E.coli BL21(ΔmsbB)。将本实验室保存的带有β-呋喃果糖苷酶(β-fructofuranosidase,β-FFase)、青霉素G 酰化酶(penicillin G acylase,PGA)基因的重组质粒pET-ffase、pET-pga分别转入敲除菌株及出发菌株中,构建工程菌株E.coli BL21(ΔmsbB)/pET-ffase、E.coli BL21(ΔwaaF)/pET-ffase、E.coli BL21(DE3)/pET-ffase、E.coli BL21(ΔmsbB)/pET-pga、E.coli BL21(ΔwaaF)/pET-pga、E.coli BL21(DE3)/pET-pga。最后通过摇瓶发酵研究敲除菌株对β-FFase、PGA胞外分泌的影响。【结果】当诱导表达4 h,以出发菌株E.coli BL21(DE3)为宿主时,β-呋喃果糖苷酶β-FFase的胞外分泌量占总表达量的2.6%,以敲除菌株ΔmsbB为宿主时,胞外分泌量达到19.7%,而以敲除菌株ΔwaaF为宿主时,胞外分泌量达到50.9%。另外,当诱导表达24 h,以敲除菌株ΔwaaF为宿主时,青霉素G酰化酶PGA的胞外酶活是出发菌株中的4.1倍,达到1708 U/L。【结论】本研究成功构建了敲除菌株ΔmsbB和ΔwaaF,ΔmsbB能明显增强β-FFase的胞外分泌,而ΔwaaF对β-FFase和PGA的胞外分泌均有显著的强化作用。     

β-呋喃果糖苷酶的固定化及其在低聚乳果糖合成中的应用

【目的】探索适宜的树脂作为载体固定β-呋喃果糖苷酶,并研究该固定化酶催化合成低聚乳果糖。【方法】选择9种大孔吸附树脂和碱性离子交换树脂固定β-呋喃果糖苷酶,筛选固定化效果较好的树脂作为载体。用聚乙烯亚胺(PEI)修饰得到PEI-树脂,采用吸附法将酶固定于PEI-树脂上,并对固定化条件进行优化。考察固定化酶的重复使用稳定性及其催化合成低聚乳果糖的能力。【结果】通过筛选发现大孔阴离子交换树脂D311固定化效果较好,经过PEI修饰后,D311固定化效果显著提高。用PEI修饰的载体PEI-D311固定果糖苷酶,最优固定化条件为:PEI浓度2%,加酶量103 U/g,吸附温度25°C,吸附p H 6.0-8.0,吸附时间8 h。最优条件下固定化酶活达57 U/g,酶活回收率达55.3%。用固定化酶催化水解1 mol/L蔗糖,重复利用15批载体酶活没有明显降低。用固定化酶催化合成低聚乳果糖,8 h内低聚乳果糖产量最高达到137 g/L。【结论】PEI-D311固定的果糖苷酶具有较好的重复使用稳定性及较高的低聚乳果糖合成能力,这为固定化酶法生产低聚乳果糖研究奠定了基础。     

枯草芽孢杆菌产β-1,3-1,4-葡聚糖酶的响应面优化

【目的】采用响应面法(RSM)优化枯草芽孢杆菌5 L发酵罐产β-1,3-1,4-葡聚糖酶的发酵条件。【方法】利用Box-Behnken设计和方差分析。【结果】获得最佳发酵条件为:转速、通气量和培养基pH分别为500 r/min、1.05 vvm和5.08,发酵时间仅为22 h产β-1,3-1,4-葡聚糖酶活力达2 294.4 U/mL。【结论】实验结果表明响应面法优化5 L发酵罐发酵产β-1,3-1,4-葡聚糖酶的条件合理可行。     

日本曲霉产β-呋喃果糖苷酶的性质研究

目的:试验确定日本曲霉产β—呋喃果糖苷酶的酶学性质。方法:将β-呋喃果糖苷酶在不同的温度、pH值、底物浓度、反应时间的条件下测定酶活。结果:确定了日本曲霉产β-呋喃果糖苷酶的性质。日本曲霉产β-呋喃果糖苷酶分子量约为89kDa,最适反应温度为50℃,最适pH值为5.5。温度在40℃-60℃,pH在5-7范围内酶比较稳定,最适底物浓度为50%,反应时间3h-4h。结论:确定了日本曲霉产β-呋喃果糖苷酶的性质,为制取高含量的低聚果糖提供条件。     

黄杆菌肝素酶Ⅱ重组菌培养条件的优化及高密度发酵

黄杆菌肝素酶Ⅱ(HepⅡ)是一类可特异性切割肝素、硫酸乙酰肝素类分子内连接键的酶。文中对黄杆菌肝素酶Ⅱ重组菌的诱导时机、诱导剂添加量、诱导温度、诱导时间等诱导产酶条件进行优化。经过优化最佳摇瓶发酵产酶条件为:37℃培养重组菌至对数生长前期,添加诱导剂IPTG至终浓度为0.3 g/L,20℃下诱导10 h,酶活达到最高,为570 U/L。在此基础上通过发酵罐高密度培养手段将菌体浓度OD600进一步提高到98,酶活大幅度提高到9 436 U/L,该研究结果为HepⅡ的工业化生产与应用奠定了良好的基础。     

Recent advances in the study of Kaposi's sarcoma-associated herpesvirus replication and pathogenesis

It has now been over twenty years since a novel herpesviral genome was identified in Kaposi's sarcoma biopsies. Since then, the cumulative research effort by molecular biologists, virologists, clinicians, and epidemiologists alike has led to the extensive characterization of this tumor virus, Kaposi's sarcoma-associated herpesvirus(KSHV; also known as human herpesvirus 8(HHV-8)), and its associated diseases. Here we review the current knowledge of KSHV biology and pathogenesis, with a particular emphasis on new and exciting advances in the field of epigenetics. We also discuss the development and practicality of various cell culture and animal model systems to study KSHV replication and pathogenesis.     

A Unique Protease Cleavage Site Predicted in the Spike Protein of the Novel Pneumonia Coronavirus (2019-nCoV) Potentially Related to Viral Transmissibility

正Dear Editor,In December 2019, a novel human coronavirus caused an epidemic of severe pneumonia(Coronavirus Disease 2019,COVID-19) in Wuhan, Hubei, China(Wu et al. 2020; Zhu et al. 2020). So far, this virus has spread to all areas of China and even to other countries. The epidemic has caused 67,102 confirmed infections with 1526 fatal cases     

Curcuminoids as inhibitors of thioredoxin reductase: A receptor based pharmacophore study with distance mapping of the active site

Curcumin is the yellow pigment of turmeric that interacts irreversibly forming an adduct with thioredoxin reductase (TrxR), an enzyme responsible for redox control of cell and defence against oxidative stress. Docking at both the active sites of TrxR was performed to compare the potency of three naturally occurring curcuminoids, namely curcumin, demethoxy curcumin and bis-demethoxy curcumin. Results show that active sites of TrxR occur at the junction of E and F chains. Volume and area of both cavities is predicted. It has been concluded by distance mapping of the most active conformations that Se atom of catalytic residue SeCYS498, is at a distance of 3.56 from C13 of demethoxy curcumin at the E chain active site, whereas C13 carbon atom forms adduct with Se atom of SeCys 498. We report that at least one methoxy group in curcuminoids is necessary for interation with catalytic residues of thioredoxin. Pharmacophore of both active sites of the TrxR receptor for curcumin and demethoxy curcumin molecules has been drawn and proposed for design and synthesis of most probable potent antiproliferative synthetic drugs.     

Comparative morphology of the carpel in the Liliaceae: Hewardieae, Petrosavieae, and Tricyrteae

The young pistils in the melanthioid tribes, Hewardieae, Petrosavieae and Tricyrteae, are uniformly tricarpellate and syncarpous. They lack raphide idioblasts. All are multiovulate, with bitegmic ovules. The Petrosavieae are marked by the presence of septal glands and incomplete syncarpy. Tepals and stamens adhere to the ovary in the Hewardieae and the Petrosavieae but not in the Tricyrteae. Two vascular bundles occur in the stamens of the Hewartlieae and Tricyrtis latifolia. Ventral bundles in the upper part of the ovary of the Hewardieae are continuous with compound septal bundles and placental bundles in the lower part. Putative ventral bundles occur in the alternate position in the Tricyrteae and putative placental bundles in the opposite. position in the Petrosavieae. The dichtomously branched stigma in each carpel of the Tricyrteae is supplied by a bifurcated dorsal bundle.     

Synthesis and antimicrobial studies of hydrazone derivatives of 4-[3-(2,4-difluorophenyl)-4-formyl-1H-pyrazol-1-yl]benzoic acid and 4-[3-(3,4-difluorophenyl)-4-formyl-1H-pyrazol-1-yl]benzoic acid

Microbial resistance to antibiotics is an unresolved global concern, which needs urgent and coordinated action. One of the guidelines of the Centers for Disease Control and Preventions (CDC) to combat antibiotic resistance is the development of new antibiotics to treat drug-resistant bacteria. In our effort to find new antibiotics, we report the synthesis and antimicrobial studies of 30 new pyrazole derivatives. These novel molecules have been synthesized by using readily available starting materials and benign reaction conditions. Some of these molecules have shown activity with MIC values as low as 0.78?µg/mL against four bacterial strains; Staphylococcus aureus, methicillin-resistant S. aureus, Bacillus subtilis, and Acinetobacter baumannii. Furthermore, active molecules are non-toxic to mammalian cell line.

     

Novel compounds with potent CDK9 inhibitory activity for the treatment of myeloma

Cyclin-dependent kinases (CDKs) and Polo-like kinases (PLKs) play key role in the regulation of the cell cycle. The aim of our study was originally the further development of our recently discovered polo-like kinase 1 (PLK1) inhibitors. A series of new 2,4-disubstituted pyrimidine derivatives were synthesized around the original hit, but their PLK1 inhibitory activity was very poor. However the novel compounds showed nanomolar CDK9 inhibitory activity and very good antiproliferative effect on multiple myeloma cell lines (RPMI-8226).